Nitrofurantoin (SR) IP 100mg

Nitroaim 100

Category Tablet

Amista Labs manufactures NitroAim-100 Tablets as a reliable and clinically proven antibiotic formulation containing Nitrofurantoin Sustained Release 100 mg. Healthcare professionals prescribe this medicine to treat and prevent urinary tract infections (UTIs) caused by susceptible bacteria. With its sustained-release technology, NitroAim-100 delivers prolonged therapeutic action, improves patient compliance, and ensures effective bacterial control in the urinary tract.

Composition

Nitrofurantoin Sustained Release IP – 100 mg

Therapeutic Indications

NitroAim-100 is widely used for:

Acute uncomplicated urinary tract infections
Recurrent UTIs
Prophylaxis of UTIs, especially in patients with frequent infections
Infections caused by E. coli, Enterococcus, Staphylococcus saprophyticus, and other sensitive uropathogens

Mechanism of Action

Nitrofurantoin interferes with multiple bacterial enzyme systems involved in carbohydrate metabolism and cell wall synthesis. This multi-target mechanism reduces the risk of bacterial resistance. After absorption, the body rapidly excretes the drug into the urine, where it reaches high concentrations and effectively eliminates urinary pathogens.

The sustained-release (SR) formulation allows gradual release of the active ingredient, maintaining consistent drug levels in the urine over an extended period and reducing dosing frequency.

Key Benefits

Targeted Action: Concentrates in the urinary tract for focused antibacterial activity
Sustained Release Formula: Provides prolonged efficacy with better tolerability
Lower Resistance Risk: Multi-site bacterial inhibition
Improved Compliance: Reduced dosing frequency compared to conventional formulations
Clinically Trusted: Commonly prescribed by healthcare professionals for UTIs

Dosage & Administration

Dosage should be taken strictly as prescribed by a physician
Usually administered orally with food to improve absorption and reduce gastric irritation
The tablet should be swallowed whole and not crushed or chewed

Safety & Precautions

Not recommended for patients with severe renal impairment
Caution advised in elderly patients and those with liver disorders
Prolonged use should be monitored by a healthcare professional
Complete the full course to prevent recurrence and resistance

Possible Side Effects

Like all medications, NitroAim-100 may cause mild side effects in some individuals, including:

Nausea or vomiting
Headache
Dizziness
Mild gastrointestinal discomfort

Severe side effects rarely occur, but patients should report them to a doctor immediately.

Storage Instructions

Store in a cool, dry place away from direct sunlight
Keep out of reach of children
Do not use after the expiry date

Packaging

Packing: 10 × 10 tablets
Dosage Form: Oral tablets

About Amista Labs

Amista Labs delivers high-quality, affordable, and effective healthcare solutions as a reputed pharmaceutical company. The company manufactures all products under stringent quality standards to ensure safety, efficacy, and consistency.

Additional information

Amista Labs is a promoting based pharmaceutical organization with its principle center around making accessible quality pharmaceutical items at reasonable expenses to all. We are ISO: 9001:2015 and WHO and GMP certified company.